Patents by Inventor Thomas James Ihrke

Thomas James Ihrke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABLE READY-TO-DRINK BEVERAGE COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE AGENTS
    Publication number: 20210235716
    Abstract: Aspects described herein relate to improved beverage compositions with lipophilic active agents and related methods. More particularly, aspects described herein relate to stable ready-to-drink beverage compositions comprising lipophilic active agents, methods of making such compositions, and methods of use.
    Type: Application
    Filed: April 26, 2021
    Publication date: August 5, 2021
    Applicant: POVIVA CORP.
    Inventors: John Docherty, Christopher Andrew Bunka, Thomas James Ihrke
  • METHODS FOR FORMULATING ORALLY INGESTIBLE COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE AGENTS
    Publication number: 20210177978
    Abstract: Aspects described herein relate to improved methods for infusing food and beverage compositions with lipophilic active agents. More particularly, aspects described herein relate to improved methods for infusing food and beverage compositions with lipophilic active agents using tapioca starch or related compounds. Lipophilic active agents include cannabinoids, nicotine, nonsteroidal anti-inflammatories (NSAIDs), and vitamins.
    Type: Application
    Filed: February 26, 2021
    Publication date: June 17, 2021
    Applicant: POVIVA CORP.
    Inventors: John Docherty, Christopher Andrew Bunka, Thomas James Ihrke
  • METHODS FOR FORMULATING ORALLY INGESTIBLE COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE AGENTS
    Publication number: 20200061195
    Abstract: Aspects described herein relate to improved methods for infusing food and beverage compositions with lipophilic active agents. More particularly, aspects described herein relate to improved methods for infusing food and beverage compositions with lipophilic active agents using tapioca starch or related compounds. Lipophilic active agents include cannabinoids, nicotine, nonsteroidal anti-inflammatories (NSAIDs), and vitamins.
    Type: Application
    Filed: October 29, 2019
    Publication date: February 27, 2020
    Inventors: John Docherty, Christopher Andrew Bunka, Thomas James Ihrke
  • STABLE READY-TO-DRINK BEVERAGE COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE AGENTS
    Publication number: 20200008442
    Abstract: Aspects described herein relate to improved beverage compositions with lipophilic active agents and related methods. More particularly, aspects described herein relate to stable ready-to-drink beverage compositions comprising lipophilic active agents, methods of making such compositions, and methods of use.
    Type: Application
    Filed: September 17, 2019
    Publication date: January 9, 2020
    Inventors: John Docherty, Christopher Andrew Bunka, Thomas James Ihrke
  • STABLE READY-TO-DRINK BEVERAGE COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE AGENTS
    Publication number: 20180116240
    Abstract: Aspects described herein relate to improved beverage compositions with lipophilic active agents and related methods. More particularly, aspects described herein relate to stable ready-to-drink beverage compositions comprising lipophilic active agents, methods of making such compositions, and methods of use.
    Type: Application
    Filed: December 1, 2016
    Publication date: May 3, 2018
    Inventors: John Docherty, Christopher Andrew Bunka, Thomas James Ihrke
  • METHODS FOR FORMULATING ORALLY INGESTIBLE COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE AGENTS
    Publication number: 20180117161
    Abstract: Aspects described herein relate to improved methods for infusing food and beverage compositions with lipophilic active agents. More particularly, aspects described herein relate to improved methods for infusing food and beverage compositions with lipophilic active agents using tapioca starch or related compounds. Lipophilic active agents include cannabinoids, nicotine, nonsteroidal anti-inflammatories (NSAIDs), and vitamins.
    Type: Application
    Filed: December 1, 2016
    Publication date: May 3, 2018
    Inventors: John Docherty, Christopher Andrew Bunka, Thomas James Ihrke